The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 18 Sep 2007
doi: 10.1242/jcs.006916
Research Article
Cholesterol suppresses cellular TGF-
responsiveness: implications in atherogenesis
Chun-Lin Chen,
I-Hua Liu,
Steven J. Fliesler,
Xianlin Han,
Shuan Shian Huang,
and
Jung San Huang*
* Author for correspondence (e-mail: huangjs{at}slu.edu)
Hypercholesterolemia is a major causative factor for atherosclerotic cardiovascular disease. The molecular mechanisms by which cholesterol initiates and facilitates the process of atherosclerosis are not well understood. Here, we demonstrate that cholesterol treatment suppresses or attenuates TGF-
responsiveness in all cell types studied as determined by measuring TGF-
-induced Smad2 phosphorylation and nuclear translocation, TGF-
-induced PAI-1 expression, TGF-
-induced luciferase reporter gene expression and TGF-
-induced growth inhibition. Cholesterol, alone or complexed in lipoproteins (LDL, VLDL), suppresses TGF-
responsiveness by increasing lipid raft and/or caveolae accumulation of TGF-
receptors and facilitating rapid degradation of TGF-
and thus suppressing TGF-
-induced signaling. Conversely, cholesterol-lowering agents (fluvastatin and lovastatin) and cholesterol-depleting agents (
-cyclodextrin and nystatin) enhance TGF-
responsiveness by increasing non-lipid raft microdomain accumulation of TGF-
receptors and facilitating TGF-
-induced signaling. Furthermore, the effects of cholesterol on the cultured cells are also found in the aortic endothelium of ApoE-null mice fed a high-cholesterol diet. These results suggest that high cholesterol contributes to atherogenesis, at least in part, by suppressing TGF-
responsiveness in vascular cells.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Banerjee, J. Ghosh, S. Sen, R. Guha, R. Dhar, M. Ghosh, S. Datta, B. Raychaudhury, K. Naskar, A. K. Haldar, et al.
Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells
Infect. Immun.,
June 1, 2009;
77(6):
2330 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chen, W.-H. Hou, I-H. Liu, G. Hsiao, S. S. Huang, and J. S. Huang
Inhibitors of clathrin-dependent endocytosis enhance TGF{beta} signaling and responses
J. Cell Sci.,
June 1, 2009;
122(11):
1863 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chung, J.-R. Sheu, H.-E. Liu, S.-C. Chang, Y.-C. Chou, W.-L. Chen, D.-S. Chou, and G. Hsiao
Dynasore, a Dynamin Inhibitor, Induces PAI-1 Expression in MeT-5A Human Pleural Mesothelial Cells
Am. J. Respir. Cell Mol. Biol.,
June 1, 2009;
40(6):
692 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zuo and Y.-G. Chen
Specific Activation of Mitogen-activated Protein Kinase by Transforming Growth Factor-{beta} Receptors in Lipid Rafts Is Required for Epithelial Cell Plasticity
Mol. Biol. Cell,
February 1, 2009;
20(3):
1020 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2007